Grupo Cibest S.A. (CIB), formerly Bancolombia S.A., is Colombia's largest financial group, operating the Bancolombia banking franchise alongside the Nequi digital-banking platform. The New York–listed American depositary receipts (ADRs) have rallied sharply over the past year, which raises a natural question for investors: can the stock reach the $110 level that the most bullish current analyst price targets imply?
Coverage of CIB has turned markedly more constructive over the past year as Colombian fundamentals improved. Of the current, individually attributed targets reviewed, the range is wide, from roughly $68 to $110. The arithmetic mean of all valid targets is approximately $87, which is actually below the latest price near $95, reflecting how much the shares have already run.
Goldman Sachs analyst Tito Labarta is among the most bullish, having upgraded the stock through 2026 to a Buy with a $110 target in August 2026. J.P. Morgan similarly lifted its target to $110 in August 2026 before later shifting its rating back to Neutral in September while keeping the target. More cautious views include BofA Securities at $75 (Neutral, June 2026), UBS at $72 (Neutral, April 2026), and Itaú BBA at $68 (Underperform, February 2026). Citigroup moved to Neutral in January 2026.
Because only the Goldman Sachs and J.P. Morgan targets sit above the current price, the central target of $110 is the average of those above-price targets. It is a bullish case, not a broad consensus — the wider analyst group leans toward a Hold stance.
At a latest price near $94.91, a move to $110 implies roughly 15.9% upside — a substantial, though not extreme, gain by the standards of an established bank. The ADRs have already climbed dramatically from a 52-week low near $59.64 to a 52-week high of $105.60 set in September 2026, before pulling back. Reaching $110 would therefore require the stock to push to a fresh high.
The path depends heavily on Colombia's macro and political backdrop. Third-quarter 2026 results showed net income attributable to shareholders of COP 2.08 trillion, down sequentially and year over year, a reminder that earnings momentum is not uniformly strong even as the valuation has re-rated higher.
The shares sit just below their 52-week high of $105.60 (September 2026), which acts as the nearest meaningful resistance. A push toward $110 would require clearing that level and breaking to new highs. On the downside, the recent consolidation near $91–$92 is a short-term support zone, with the 52-week low near $59.64 defining the long-term floor of the rally.
Analyst price targets generally reflect a roughly 12-month research horizon, though the exact timeframe varies by firm. Investors should watch Colombia's presidential runoff, upcoming quarterly earnings and net interest margin trends, analyst rating and target revisions, central-bank interest-rate decisions, and the peso's direction. Dividend and capital-return updates also matter given the stock's income appeal.
For traders who prefer a data-driven approach, Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. The tool is designed to help traders discover opportunities, monitor positions, and spot shifting trends more efficiently than manual screening alone.
Whether CIB can reach $110 ultimately hinges on a bullish scenario — reflected only in the Goldman Sachs and J.P. Morgan targets — rather than the broader, more cautious consensus, whose average sits near $87. A roughly 16% advance would require the shares to break above their recent record high near $105.60 and for Colombia's improving political backdrop, digital growth, and stable profitability to outweigh the drag from lower rates, currency risk, and an already extended valuation. The wide $68-to-$110 target range underscores genuine disagreement among analysts, and investors should treat the $110 figure as an aspirational bull case rather than a consensus expectation.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, CIB has been loosely correlated with BSAC. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CIB jumps, then BSAC could also see price increases.
| Ticker / NAME | Correlation To CIB | 1D Price Change % | ||
|---|---|---|---|---|
| CIB | 100% | +0.98% | ||
| BSAC - CIB | 57% Loosely correlated | +1.44% | ||
| AVAL - CIB | 56% Loosely correlated | +2.78% | ||
| BCH - CIB | 52% Loosely correlated | +1.42% | ||
| BAP - CIB | 50% Loosely correlated | +0.93% | ||
| SUPV - CIB | 50% Loosely correlated | +4.58% | ||
More | ||||
| Ticker / NAME | Correlation To CIB | 1D Price Change % |
|---|---|---|
| CIB | 100% | +0.98% |
| Banks category (429 stocks) | 23% Poorly correlated | +0.47% |
| Regional Banks category (356 stocks) | 20% Poorly correlated | +0.39% |